2016 Clinical Trials Conditions Consumption 
The Cannigma
MAY 19, 2021
Since 2016, the country has permitted the sale of CBD and some Japanese companies produce cannabidiol products as well. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. That could potentially change in the near future, however. Shutterstock).
The Cannigma
MAY 13, 2022
There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. A 2016 study found that patients with chronic pain who used cannabis had a 64% reduction in opioid use, reported a better quality of life, and used fewer medications overall to manage their pain. Best terpenes for pain.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaMD
AUGUST 26, 2020
Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., Conditioned place preference. mice/rats). The studies were then broken into eight categories: Cocaine self-administration. Brain-stimulation reward. Hepatic protection.
Cannabis Law Report
JANUARY 24, 2022
The CBD segment dominated the market in 2021 due to the growing awareness about the positive effects of CBD for the treatment of various medical conditions, such as chronic pain, cancer & multiple sclerosis. North America Legal Cannabis Number of clinical trials. Hemp Market Estimates and Forecasts, 2016-2028 (USD Million).
The Cannigma
JANUARY 13, 2023
Migraines are a peculiarly painful condition. Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. A primary headache, such as a migraine, is its own condition, and not caused by a separate condition.
FloridaMarijuana.net
AUGUST 13, 2018
Florida medical marijuana doctors are recommending medical marijuana for anxiety, depression and many other mental health conditions. Anxiety is one aspect of a broader condition- anxiety disorder. The authors conclude that: Mental health conditions are prominent among the reasons for medical cannabis use.
Cannabis Law Report
JUNE 11, 2019
The accident also reactivated a pre-existing psychological condition which manifested as a chronic pain syndrome, and a pre-existing depressive disorder which was in partial remission at the time of trial. Indeed, the experts were unanimous in concluding that his present level of consumption is excessive. White , 2016 BCSC 569.
Expert insights. Personalized for you.
137 
Let's personalize your content